company

PAXNOR PHARMA AS

1365 BLOMMENHOLM

Return on Equity
−19,86 %
Current Ratio
2,16
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 111 000
Net Income−56 000
Total Assets526 000
Total Equity282 000
Income (NOK)2022
Revenue2 111 000
Expenditure2 166 000
Operating Profit−56 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−56 000
Tax0
Net Income−56 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets526 000
Total Assets526 000
Total Retained Equity252 000
Total Equity282 000
Total Long-Term Debt0
Total Current Debt244 000
Total Equity and Debt526 000
Cash flow (NOK)2022
Sales Income2 111 000
Other Income0
Revenue2 111 000
Cost of Goods Sold1 000
Salary Costs1 602 000
Depreciation0
Impairment0
Expenditure2 166 000
Operating Profit−56 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−56 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank517 000
Total Current Assets526 000
Total Assets526 000
Total Equity282 000
Short-Term Group Debt−12 000
Total Long-Term Debt0
Creditors0
Unpaid Taxes71 000
Dividends0
Other Current Debt185 000
Total Current Debt244 000
Total Equity and Debt526 000
Financial indicators2022
Return on Equity−19,86 %
Debt-to-Equity Ratio0
Operating Profit Margin−2,65 %
Current Ratio2,16
Quick Ratio2,16
Equity Ratio0,54
Gross Profit Margin99,95 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English